Evidence map›Paper›PMID 31454890›Full record

ArticleInternational journal of molecular sciences2019

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.

Ting Chang, Hsin-Ling Ho, Shao-Jung Hsu, Ching-Chih Chang, Ming-Hung Tsai, Teh-Ia Huo, Hui-Chun Huang, Fa-Yauh Lee, Ming-Chih Hou, Shou-Dong Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Platelet activation relieves liver portal hypertensionWorld journal of gastroenterology · 2025
    Article
  2. Article
  3. Glucosinolate Diversity Analysis in Choy Sum (Foods (Basel, Switzerland) · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ting ChangDivision of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.ORCID 0000-0003-0634-6478
Hsin-Ling HoInstitute of Pharmacology, National Yang-Ming University School of Medicine, Taipei 11217, Taiwan.
Shao-Jung HsuFaculty of Medicine, National Yang-Ming University School of Medicine, Taipei 11217, Taiwan.
Ching-Chih ChangDivision of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan. ccchang7@vghtpe.gov.tw.ORCID 0000-0001-5526-5389
Ming-Hung TsaiChang Gung University College of Medicine and Division of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.
Teh-Ia HuoInstitute of Pharmacology, National Yang-Ming University School of Medicine, Taipei 11217, Taiwan.
Hui-Chun HuangDivision of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Fa-Yauh LeeDivision of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Ming-Chih HouFaculty of Medicine, National Yang-Ming University School of Medicine, Taipei 11217, Taiwan.
Shou-Dong LeeFaculty of Medicine, National Yang-Ming University School of Medicine, Taipei 11217, Taiwan.
National Yang Ming Chiao Tung University · TWChang Gung University · TWTaipei Veterans General Hospital · TW

Funding

Szu-Zuan Research Foundation of Internal Medicine No. 108009Taipei Veterans General Hospital V105C-032
6 · The paper itself

Abstract

Patients suffering from liver cirrhosis are often complicated with the formation of portosystemic collateral vessels, which is associated with the progression of a splanchnic hyperdynamic circulatory state. Alleviating pathological angiogenesis has thus been proposed to be a feasible treatment strategy. Indole-3-carbinol (C9H9NO, I3C) and 3,3'-diindolymethane (DIM), formed by the breakdown of glucosinolate glucobrassicin, are prevalent in cruciferous vegetables and have anti-angiogenesis properties. We aimed to evaluate their influences on portal hypertension, the severity of mesenteric angiogenesis, and portosystemic collaterals in cirrhosis. Sprague-Dawley rats with common bile duct ligation (CBDL)-induced liver cirrhosis or sham operation (surgical control) were randomly allocated to receive I3C (20 mg/kg/3 day), DIM (5 mg/kg/day) or vehicle for 28 days. The systemic and portal hemodynamics, severity of portosystemic shunting, mesenteric angiogenesis, and mesenteric proangiogenic factors protein expressions were evaluated. Compared to vehicle, both DIM and I3C significantly reduced portal pressure, ameliorated liver fibrosis, and down-regulated mesenteric protein expressions of vascular endothelial growth factor and phosphorylated Akt. DIM significantly down-regulated pErk, and I3C down-regulated NFκB, pIκBα protein expressions, and reduced portosystemic shunting degree. The cruciferous vegetable byproducts I3C and DIM not only exerted a portal hypotensive effect but also ameliorated abnormal angiogenesis and portosystemic collaterals in cirrhotic rats.

Indexed as

Angiogenesis InhibitorsAngiographyAnimalsAnti-Inflammatory Agents, Non-SteroidalBiomarkersBody WeightDisease Models, AnimalGlucosinolatesHemodynamicsHypertension, PortalIndolesLiver CirrhosisModels, BiologicalOrgan SizeRatsAngiogenesis InhibitorsAnti-Inflammatory Agents, Non-SteroidalBiomarkersglucobrassicinGlucosinolatesIndoles3,3′-diindolymethane (DIM)angiogenesisindole-3-carbinol (I3C)liver cirrhosisportosystemic collaterals

Identifiers

PMID31454890
PMCPMC6747388
OpenAlexW2969514926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.